Merging iPSC models and human genetic research has opened up new avenues in understanding disease mechanisms and target biology, which facilitate exciting translation of this research to many areas of drug development. We highlight recent applications of these combined disciplines and discuss remaining challenges and potential solutions.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.stem.2017.07.012 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!